Global Cellulite Treatment Market Size, Share & Trends Analysis Report By Gender (Female and Male), By Procedure Type, By Cellulite Type, By End User (Clinics & Beauty Centers, Hospitals and Others), By Regional Outlook and Forecast, 2024 - 2031

Global Cellulite Treatment Market Size, Share & Trends Analysis Report By Gender (Female and Male), By Procedure Type, By Cellulite Type, By End User (Clinics & Beauty Centers, Hospitals and Others), By Regional Outlook and Forecast, 2024 - 2031


The Global Cellulite Treatment Market size is expected to reach $5.4 billion by 2031, rising at a market growth of 10.1% CAGR during the forecast period.

Using high-energy acoustic waves, a relatively new treatment option known as acoustic wave therapy targets and targets cellulite in order to break it down. This non-invasive treatment has been shown to improve the appearance of cellulite, reduce skin laxity, and improve overall skin texture. Consequently, the non-invasive would generate approximately 43.0 % share in the market by 2031. These treatments are more effective, safer, and more comfortable than traditional surgical procedures. As a result, more patients opt for these innovative treatments to achieve smoother, firmer, and more youthful-looking skin.

As more individuals become aware of cellulite's impact on their appearance and self-esteem, there has been a corresponding surge in the demand for effective treatments to address this common aesthetic concern. This heightened awareness has been fostered by major international bodies, organizations, and associations dedicated to promoting skin health and raising awareness about cellulite. Hence, the increasing awareness and concern about cellulite have driven the demand for cellulite treatments.

Additionally, As people age, their skin loses elasticity and firmness, making them more prone to cellulite. According to the World Health Organization, one in six people will be 60 or older by 2030. At this time, there will be approximately 1.4 billion people aged 60 or older, a significant increase over the 1 billion projected for 2020. Thus, this demographic trend has increased the demand for cellulite treatments.

However, Cellulite treatments can vary widely in cost depending on the type of treatment and the provider. More advanced or invasive procedures, such as laser therapy or radiofrequency treatments, are more expensive than non-invasive options. Thus, the high cost of effective cellulite treatments may deter their adoption, limiting the market's growth.

Furthermore, The pandemic led to a delay in treatment-seeking behavior among some consumers. Economic uncertainty and concerns about the virus caused some individuals to postpone cosmetic procedures, including cellulite treatments until the situation improves. This delay impacted providers' revenue and led to a backlog of patients seeking treatment. Thus, the pandemic had an overall negative impact on the market.

By Gender Analysis

Based on gender, the market is segmented into male and female. The male segment acquired a 27.05 % revenue share in the market in 2023. Men increasingly seek treatments to improve their appearance and address aesthetic concerns, including cellulite. Additionally, as the stigma surrounding cosmetic procedures diminishes, more men are exploring options to enhance their physical appearance, including reducing the appearance of cellulite. According to the gender breakouts for the 2022 American Society of Plastic Surgeons (ASPS) Procedural Statistics, men accounted for exceptional growth – a 207% rise in total cosmetic procedures since 2019.

By Procedure Type Analysis

On the basis of procedure type, the market is classified into non-invasive, minimally invasive, and topical. The non-invasive segment acquired the 44.14 % revenue share in the market in 2023. Patients are able to return to their regular activities almost immediately after receiving non-invasive treatments because these treatments typically require only a short period of downtime. This convenience attracts those with busy lifestyles who cannot afford extended recovery periods. As technology advances, non-invasive treatments are likely to become even more popular among those looking to improve the appearance of their skin.

By Cellulite Type Analysis

Based on cellulite type, the market is characterized into soft cellulite, hard cellulite, and edematous. The edematous segment procured a 15.47 % growth rate in the market in 2023. Edematous cellulite is a type of cellulite characterized by fluid retention and swelling in the affected areas. Hormonal imbalances, poor circulation, and lifestyle factors like diet and exercise are factors that are frequently associated with this condition. The demand for edematous cellulite treatment is on the rise, driven by several factors, including increasing awareness of cellulite as a common concern, the desire for smoother skin, and advancements in treatment options.

By End-User Analysis

By end user, the market is divided into hospitals, clinics & beauty centers, and others. The clinics & beauty centers segment witnessed the 52.27 % revenue share in the market in 2023. Aestheticians, dermatologists, and trained technicians are examples of the types of skilled professionals that are frequently employed by beauty centers and clinics that specialize in the treatment of cellulite. These professionals have extensive experience using these treatments. They may also offer complementary services, such as body contouring and skin tightening treatments, to enhance the results of cellulite reduction procedures.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific segment witnessed a 18.45 % growth rate in the market in 2023. Countries such as China, India, and Japan are driving market growth. These countries have large populations with increasing disposable income levels, leading to a growing demand for aesthetic procedures, including cellulite treatments. Additionally, the influence of Western beauty standards and the rise of social media contribute to the growing acceptance of cellulite treatments in these regions.

Recent Strategies Deployed in the Market
  • Jan-2024: Solta Medical, a subsidiary of Bausch Health Companies Inc., has received approval from China's National Medical Product Administration (NMPA) for its Thermage FLX and the TR-4 Return pad. These are non-invasive treatments utilizing radiofrequency technology aimed at tightening and enhancing the smoothness and texture of the skin's surface, ultimately optimizing a patient's appearance. Thermage proves versatile and effective, suitable for all skin types and genders, and applicable to various areas on the face, body, and around the eyes.
  • Mar-2023: Sinclair Pharma Ltd. has introduced a novel product called Lanluma, a collagen-stimulating injectable filler. Lanluma is designed to reshape, volumize, and enhance body contours. The minimally invasive treatment entails the injection of Poly-L-lactic acid (PLLA), which enhances skin tightness and texture, augments curves in flat or sagging buttocks, reduces cellulite and dimples, enhances buttock shape and volume, and addresses natural or post-surgical concerns like atrophy and lipoatrophy.
  • Feb-2023: Candela Corporation introduces its latest innovation, the Profound Matrix system, designed for radiofrequency-based skin treatments. This system employs radiofrequency microneedles to address skin concerns across various stages of the aging process. With features like Sublime, Sublative RF, and the new Matrix Pro applications, it provides bipolar radiofrequency treatment to improve the appearance of fine lines and wrinkles.
  • Aug-2022: Allergan Aesthetics, an AbbVie company, launches SkinMedica® Firm & Tone Lotion for Body, the inaugural product from its professional-grade skincare line. Formulated to combat visible signs of body skin aging, it addresses crepey skin, uneven texture, firmness, tone, and sagging. Featuring ingredients like Green Microalgae, Shitake Mushroom Extracts, Lemon Balm Extract, Coffea Arabica Seed Oil, Caffeine, Hydrolyzed Rice Protein, and Japanese Parsley, it supports various skin functions including dermal extracellular matrix components, cellular clearance and recycling, antioxidant protection, and balanced lipid metabolism.
  • Feb-2022: Sinclair Pharma Ltd. has entered into an agreement with Viora Ltd., a medical device company specializing in medical aesthetic systems. The agreement involves Sinclair's acquisition of Viora, enhancing Sinclair Cocoon's product range and extending its commercial footprint in the United States through various technologies.
  • Dec-2021: Allergan Aesthetics, a subsidiary of AbbVie Inc., has finalized the acquisition of Soliton, Inc., a medical device company specializing in acoustic shockwave technology for tattoo and cellulite removal. With this acquisition, the company seeks to enhance its solution portfolio by integrating a proven treatment for cellulite, complementing its existing range of non-invasive body contouring treatments.
List of Key Companies Profiled
  • Candela Corporation (Syneron Medical)
  • Bausch Health Companies, Inc.
  • Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
  • AbbVie, Inc.
  • Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
  • Hologic, Inc.
  • Galderma S.A.
  • Zimmer MedizinSysteme GmbH
  • Endo International PLC
  • Merz Pharma GmbH & Co. KGaA
Global Cellulite Treatment Market Report Segmentation

By Gender
  • Female
  • Male
By Procedure Type
  • Non-invasive
  • Topical
  • Minimally Invasive
By Cellulite Type
  • Soft Cellulite
  • Hard Cellulite
  • Edematous
By End User
  • Clinics & Beauty Centers
  • Hospitals
  • Others
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Cellulite Treatment Market, by Gender
1.4.2 Global Cellulite Treatment Market, by Procedure Type
1.4.3 Global Cellulite Treatment Market, by Cellulite Type
1.4.4 Global Cellulite Treatment Market, by End User
1.4.5 Global Cellulite Treatment Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Recent Strategies Deployed in Cellulite Treatment Market
Chapter 5. Global Cellulite Treatment Market by Gender
5.1 Global Female Market by Region
5.2 Global Male Market by Region
Chapter 6. Global Cellulite Treatment Market by Procedure Type
6.1 Global Non-invasive Market by Region
6.2 Global Topical Market by Region
6.3 Global Minimally Invasive Market by Region
Chapter 7. Global Cellulite Treatment Market by Cellulite Type
7.1 Global Soft Cellulite Market by Region
7.2 Global Hard Cellulite Market by Region
7.3 Global Edematous Market by Region
Chapter 8. Global Cellulite Treatment Market by End User
8.1 Global Clinics & Beauty Centers Market by Region
8.2 Global Hospitals Market by Region
8.3 Global Others Market by Region
Chapter 9. Global Cellulite Treatment Market by Region
9.1 North America Cellulite Treatment Market
9.1.1 North America Cellulite Treatment Market by Gender
9.1.1.1 North America Female Market by Region
9.1.1.2 North America Male Market by Region
9.1.2 North America Cellulite Treatment Market by Procedure Type
9.1.2.1 North America Non-invasive Market by Country
9.1.2.2 North America Topical Market by Country
9.1.2.3 North America Minimally Invasive Market by Country
9.1.3 North America Cellulite Treatment Market by Cellulite Type
9.1.3.1 North America Soft Cellulite Market by Country
9.1.3.2 North America Hard Cellulite Market by Country
9.1.3.3 North America Edematous Market by Country
9.1.4 North America Cellulite Treatment Market by End User
9.1.4.1 North America Clinics & Beauty Centers Market by Country
9.1.4.2 North America Hospitals Market by Country
9.1.4.3 North America Others Market by Country
9.1.5 North America Cellulite Treatment Market by Country
9.1.5.1 US Cellulite Treatment Market
9.1.5.1.1 US Cellulite Treatment Market by Gender
9.1.5.1.2 US Cellulite Treatment Market by Procedure Type
9.1.5.1.3 US Cellulite Treatment Market by Cellulite Type
9.1.5.1.4 US Cellulite Treatment Market by End User
9.1.5.2 Canada Cellulite Treatment Market
9.1.5.2.1 Canada Cellulite Treatment Market by Gender
9.1.5.2.2 Canada Cellulite Treatment Market by Procedure Type
9.1.5.2.3 Canada Cellulite Treatment Market by Cellulite Type
9.1.5.2.4 Canada Cellulite Treatment Market by End User
9.1.5.3 Mexico Cellulite Treatment Market
9.1.5.3.1 Mexico Cellulite Treatment Market by Gender
9.1.5.3.2 Mexico Cellulite Treatment Market by Procedure Type
9.1.5.3.3 Mexico Cellulite Treatment Market by Cellulite Type
9.1.5.3.4 Mexico Cellulite Treatment Market by End User
9.1.5.4 Rest of North America Cellulite Treatment Market
9.1.5.4.1 Rest of North America Cellulite Treatment Market by Gender
9.1.5.4.2 Rest of North America Cellulite Treatment Market by Procedure Type
9.1.5.4.3 Rest of North America Cellulite Treatment Market by Cellulite Type
9.1.5.4.4 Rest of North America Cellulite Treatment Market by End User
9.2 Europe Cellulite Treatment Market
9.2.1 Europe Cellulite Treatment Market by Gender
9.2.1.1 Europe Female Market by Country
9.2.1.2 Europe Male Market by Country
9.2.2 Europe Cellulite Treatment Market by Procedure Type
9.2.2.1 Europe Non-invasive Market by Country
9.2.2.2 Europe Topical Market by Country
9.2.2.3 Europe Minimally Invasive Market by Country
9.2.3 Europe Cellulite Treatment Market by Cellulite Type
9.2.3.1 Europe Soft Cellulite Market by Country
9.2.3.2 Europe Hard Cellulite Market by Country
9.2.3.3 Europe Edematous Market by Country
9.2.4 Europe Cellulite Treatment Market by End User
9.2.4.1 Europe Clinics & Beauty Centers Market by Country
9.2.4.2 Europe Hospitals Market by Country
9.2.4.3 Europe Others Market by Country
9.2.5 Europe Cellulite Treatment Market by Country
9.2.5.1 Germany Cellulite Treatment Market
9.2.5.1.1 Germany Cellulite Treatment Market by Gender
9.2.5.1.2 Germany Cellulite Treatment Market by Procedure Type
9.2.5.1.3 Germany Cellulite Treatment Market by Cellulite Type
9.2.5.1.4 Germany Cellulite Treatment Market by End User
9.2.5.2 UK Cellulite Treatment Market
9.2.5.2.1 UK Cellulite Treatment Market by Gender
9.2.5.2.2 UK Cellulite Treatment Market by Procedure Type
9.2.5.2.3 UK Cellulite Treatment Market by Cellulite Type
9.2.5.2.4 UK Cellulite Treatment Market by End User
9.2.5.3 France Cellulite Treatment Market
9.2.5.3.1 France Cellulite Treatment Market by Gender
9.2.5.3.2 France Cellulite Treatment Market by Procedure Type
9.2.5.3.3 France Cellulite Treatment Market by Cellulite Type
9.2.5.3.4 France Cellulite Treatment Market by End User
9.2.5.4 Russia Cellulite Treatment Market
9.2.5.4.1 Russia Cellulite Treatment Market by Gender
9.2.5.4.2 Russia Cellulite Treatment Market by Procedure Type
9.2.5.4.3 Russia Cellulite Treatment Market by Cellulite Type
9.2.5.4.4 Russia Cellulite Treatment Market by End User
9.2.5.5 Spain Cellulite Treatment Market
9.2.5.5.1 Spain Cellulite Treatment Market by Gender
9.2.5.5.2 Spain Cellulite Treatment Market by Procedure Type
9.2.5.5.3 Spain Cellulite Treatment Market by Cellulite Type
9.2.5.5.4 Spain Cellulite Treatment Market by End User
9.2.5.6 Italy Cellulite Treatment Market
9.2.5.6.1 Italy Cellulite Treatment Market by Gender
9.2.5.6.2 Italy Cellulite Treatment Market by Procedure Type
9.2.5.6.3 Italy Cellulite Treatment Market by Cellulite Type
9.2.5.6.4 Italy Cellulite Treatment Market by End User
9.2.5.7 Rest of Europe Cellulite Treatment Market
9.2.5.7.1 Rest of Europe Cellulite Treatment Market by Gender
9.2.5.7.2 Rest of Europe Cellulite Treatment Market by Procedure Type
9.2.5.7.3 Rest of Europe Cellulite Treatment Market by Cellulite Type
9.2.5.7.4 Rest of Europe Cellulite Treatment Market by End User
9.3 Asia Pacific Cellulite Treatment Market
9.3.1 Asia Pacific Cellulite Treatment Market by Gender
9.3.1.1 Asia Pacific Female Market by Country
9.3.1.2 Asia Pacific Male Market by Country
9.3.2 Asia Pacific Cellulite Treatment Market by Procedure Type
9.3.2.1 Asia Pacific Non-invasive Market by Country
9.3.2.2 Asia Pacific Topical Market by Country
9.3.2.3 Asia Pacific Minimally Invasive Market by Country
9.3.3 Asia Pacific Cellulite Treatment Market by Cellulite Type
9.3.3.1 Asia Pacific Soft Cellulite Market by Country
9.3.3.2 Asia Pacific Hard Cellulite Market by Country
9.3.3.3 Asia Pacific Edematous Market by Country
9.3.4 Asia Pacific Cellulite Treatment Market by End User
9.3.4.1 Asia Pacific Clinics & Beauty Centers Market by Country
9.3.4.2 Asia Pacific Hospitals Market by Country
9.3.4.3 Asia Pacific Others Market by Country
9.3.5 Asia Pacific Cellulite Treatment Market by Country
9.3.5.1 China Cellulite Treatment Market
9.3.5.1.1 China Cellulite Treatment Market by Gender
9.3.5.1.2 China Cellulite Treatment Market by Procedure Type
9.3.5.1.3 China Cellulite Treatment Market by Cellulite Type
9.3.5.1.4 China Cellulite Treatment Market by End User
9.3.5.2 Japan Cellulite Treatment Market
9.3.5.2.1 Japan Cellulite Treatment Market by Gender
9.3.5.2.2 Japan Cellulite Treatment Market by Procedure Type
9.3.5.2.3 Japan Cellulite Treatment Market by Cellulite Type
9.3.5.2.4 Japan Cellulite Treatment Market by End User
9.3.5.3 India Cellulite Treatment Market
9.3.5.3.1 India Cellulite Treatment Market by Gender
9.3.5.3.2 India Cellulite Treatment Market by Procedure Type
9.3.5.3.3 India Cellulite Treatment Market by Cellulite Type
9.3.5.3.4 India Cellulite Treatment Market by End User
9.3.5.4 South Korea Cellulite Treatment Market
9.3.5.4.1 South Korea Cellulite Treatment Market by Gender
9.3.5.4.2 South Korea Cellulite Treatment Market by Procedure Type
9.3.5.4.3 South Korea Cellulite Treatment Market by Cellulite Type
9.3.5.4.4 South Korea Cellulite Treatment Market by End User
9.3.5.5 Singapore Cellulite Treatment Market
9.3.5.5.1 Singapore Cellulite Treatment Market by Gender
9.3.5.5.2 Singapore Cellulite Treatment Market by Procedure Type
9.3.5.5.3 Singapore Cellulite Treatment Market by Cellulite Type
9.3.5.5.4 Singapore Cellulite Treatment Market by End User
9.3.5.6 Malaysia Cellulite Treatment Market
9.3.5.6.1 Malaysia Cellulite Treatment Market by Gender
9.3.5.6.2 Malaysia Cellulite Treatment Market by Procedure Type
9.3.5.6.3 Malaysia Cellulite Treatment Market by Cellulite Type
9.3.5.6.4 Malaysia Cellulite Treatment Market by End User
9.3.5.7 Rest of Asia Pacific Cellulite Treatment Market
9.3.5.7.1 Rest of Asia Pacific Cellulite Treatment Market by Gender
9.3.5.7.2 Rest of Asia Pacific Cellulite Treatment Market by Procedure Type
9.3.5.7.3 Rest of Asia Pacific Cellulite Treatment Market by Cellulite Type
9.3.5.7.4 Rest of Asia Pacific Cellulite Treatment Market by End User
9.4 LAMEA Cellulite Treatment Market
9.4.1 LAMEA Cellulite Treatment Market by Gender
9.4.1.1 LAMEA Female Market by Country
9.4.1.2 LAMEA Male Market by Country
9.4.2 LAMEA Cellulite Treatment Market by Procedure Type
9.4.2.1 LAMEA Non-invasive Market by Country
9.4.2.2 LAMEA Topical Market by Country
9.4.2.3 LAMEA Minimally Invasive Market by Country
9.4.3 LAMEA Cellulite Treatment Market by Cellulite Type
9.4.3.1 LAMEA Soft Cellulite Market by Country
9.4.3.2 LAMEA Hard Cellulite Market by Country
9.4.3.3 LAMEA Edematous Market by Country
9.4.4 LAMEA Cellulite Treatment Market by End User
9.4.4.1 LAMEA Clinics & Beauty Centers Market by Country
9.4.4.2 LAMEA Hospitals Market by Country
9.4.4.3 LAMEA Others Market by Country
9.4.5 LAMEA Cellulite Treatment Market by Country
9.4.5.1 Brazil Cellulite Treatment Market
9.4.5.1.1 Brazil Cellulite Treatment Market by Gender
9.4.5.1.2 Brazil Cellulite Treatment Market by Procedure Type
9.4.5.1.3 Brazil Cellulite Treatment Market by Cellulite Type
9.4.5.1.4 Brazil Cellulite Treatment Market by End User
9.4.5.2 Argentina Cellulite Treatment Market
9.4.5.2.1 Argentina Cellulite Treatment Market by Gender
9.4.5.2.2 Argentina Cellulite Treatment Market by Procedure Type
9.4.5.2.3 Argentina Cellulite Treatment Market by Cellulite Type
9.4.5.2.4 Argentina Cellulite Treatment Market by End User
9.4.5.3 UAE Cellulite Treatment Market
9.4.5.3.1 UAE Cellulite Treatment Market by Gender
9.4.5.3.2 UAE Cellulite Treatment Market by Procedure Type
9.4.5.3.3 UAE Cellulite Treatment Market by Cellulite Type
9.4.5.3.4 UAE Cellulite Treatment Market by End User
9.4.5.4 Saudi Arabia Cellulite Treatment Market
9.4.5.4.1 Saudi Arabia Cellulite Treatment Market by Gender
9.4.5.4.2 Saudi Arabia Cellulite Treatment Market by Procedure Type
9.4.5.4.3 Saudi Arabia Cellulite Treatment Market by Cellulite Type
9.4.5.4.4 Saudi Arabia Cellulite Treatment Market by End User
9.4.5.5 South Africa Cellulite Treatment Market
9.4.5.5.1 South Africa Cellulite Treatment Market by Gender
9.4.5.5.2 South Africa Cellulite Treatment Market by Procedure Type
9.4.5.5.3 South Africa Cellulite Treatment Market by Cellulite Type
9.4.5.5.4 South Africa Cellulite Treatment Market by End User
9.4.5.6 Nigeria Cellulite Treatment Market
9.4.5.6.1 Nigeria Cellulite Treatment Market by Gender
9.4.5.6.2 Nigeria Cellulite Treatment Market by Procedure Type
9.4.5.6.3 Nigeria Cellulite Treatment Market by Cellulite Type
9.4.5.6.4 Nigeria Cellulite Treatment Market by End User
9.4.5.7 Rest of LAMEA Cellulite Treatment Market
9.4.5.7.1 Rest of LAMEA Cellulite Treatment Market by Gender
9.4.5.7.2 Rest of LAMEA Cellulite Treatment Market by Procedure Type
9.4.5.7.3 Rest of LAMEA Cellulite Treatment Market by Cellulite Type
9.4.5.7.4 Rest of LAMEA Cellulite Treatment Market by End User
Chapter 10. Company Profiles
10.1 Candela corporation (Syneron Medical)
10.1.1 Company Overview
10.1.2 Recent strategies and developments:
10.1.2.1 Partnerships, Collaborations, and Agreements:
10.1.2.2 Product Launches and Product Expansions:
10.1.3 SWOT Analysis
10.2 Bausch Health Companies, Inc
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Trials and Approvals:
10.2.6 SWOT Analysis
10.3 Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
10.3.1 Company Overview
10.3.2 Recent strategies and developments:
10.3.2.1 Partnerships, Collaborations, and Agreements:
10.3.2.2 Product Launches and Product Expansions:
10.3.3 SWOT Analysis
10.4 AbbVie, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Product Launches and Product Expansions:
10.4.5.2 Acquisition and Mergers:
10.4.6 SWOT Analysis
10.5 Hologic, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 SWOT Analysis
10.6 Galderma S.A.
10.6.1 Company Overview
10.6.2 SWOT Analysis
10.7 Endo International PLC
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental Analysis
10.7.4 Research & Development Expense
10.7.5 Recent strategies and developments:
10.7.5.1 Trials and Approvals:
10.7.5.2 Acquisition and Mergers:
10.7.6 SWOT Analysis
10.8 Merz Pharma GmbH & Co. KGaA
10.8.1 Company Overview
10.8.2 SWOT Analysis
10.9 Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
10.9.1 Company Overview
10.9.2 SWOT Analysis
10.10. Zimmer MedizinSysteme GmbH
10.10.1 Company Overview
10.10.2 SWOT Analysis
Chapter 11. Winning Imperatives of Cellulite Treatment Market

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings